Status:
COMPLETED
DERM Health Economics Study
Lead Sponsor:
Skin Analytics Limited
Collaborating Sponsors:
Innovate UK
Conditions:
Melanoma
Non-melanoma Skin Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to provide an initial assessment of the potential impact DERM could have on the number of onward referrals for a face to face dermatologist review and/or biopsy from a teledermatology-...
Detailed Description
DERM, an Artificial Intelligence (AI)-based diagnosis support tool, has been shown to be able to accurately identify melanoma, non-melanoma skin cancers (NMSC) and other conditions from historical ima...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study,
- Male or Female, aged 18 years or above,
- Has at least one suspicious skin lesion which is being photographed as part of Standard of Care (SoC),
- In the Investigators opinion, able and willing to comply with all study requirements.
Exclusion
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
Key Trial Info
Start Date :
February 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 6 2021
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04123678
Start Date
February 26 2020
End Date
August 6 2021
Last Update
August 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chelsea and Westminster Hospital
London, United Kingdom, SW10 9NH